Key points
- FY27 revenue guidance upgraded to $37.5m to $40.0m
- Reflects growth of 77% to 89% on FY26 revenue
- Upgrade driven by strong contract conversion and momentum
- ANSTO contract validates Engineering pipeline quality
Full summary
Synertec Corporation Limited (ASX: SOP) has upgraded its FY27 revenue guidance to between $37.5 million and $40.0 million, representing a significant increase from the previous guidance of $29.5 million to $31.7 million. This upgrade reflects strong contract conversion, particularly in the Engineering business, and continued growth across government, healthcare, nuclear, and critical infrastructure markets. The recent $45.5 million ANSTO Nuclear Medicine Manufacturing Program contract, while a notable achievement, only marginally increased the previously disclosed Engineering pipeline, validating the quality and probability-weighted approach of Synertec's pipeline reporting. The upgrade also highlights accelerating commercial momentum and project progression in the Powerhouse business, increased revenue visibility from contracted work, and the benefits of the company's industry diversification and geographic expansion strategy.
Guidance
FY27 revenue guidance upgraded to $37.5 million to $40.0 million
Outlook
Synertec anticipates continued growth driven by strong contract conversion, operational momentum, and diversification across multiple sectors and geographies.